Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 5/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6895716 | 0.97 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL14446110 | 0.97 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL6966694 | 0.86 | — | — | |
| SCHEMBL1685460 | 0.85 | SIGMAR1 (0.41) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL24437912 | 0.83 | SIGMAR1 (0.45) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL10170019 | 0.83 | ADH1A (0.39) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL17394826 | 0.81 | SIGMAR1 (0.48) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL7185981 | 0.79 | SIGMAR1 (0.34) | CYP2D6CYP2C9SIGMAR1ADH1AEPHX1 | |
| SCHEMBL10170018 | 0.78 | SIGMAR1 (0.38) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL243850 | 0.78 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116917269-B | Process for producing isocyanate compound | Hanwha Solutions Co.,Ltd. (KR) | 2026-05-26 | — | — | CN | claimed |
| CN-115043868-B | Five-membered cyclic aminosilane external electron donor, preparation method and application thereof | 中国科学院化学研究所 | 2024-10-29 | — | — | CN | claimed |
| CN-118412471-B | Composite material for preparing positive electrode material, and preparation method and application thereof | 上海交通大学 | 2024-09-20 | — | — | CN | claimed |
| CN-118412471-A | Composite material for preparing positive electrode material, and preparation method and application thereof | 上海交通大学 | 2024-07-30 | — | — | CN | claimed |
| CN-116917269-A | Process for producing isocyanate compound | 韩华思路信(株) | 2023-10-20 | — | — | CN | claimed |
| WO-2011089559-A1 | A NOVEL POLYMORPHIC FORM OF ATORVASTATIN SALTS | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2011-07-28 | — | — | WO | claimed |
| EP-1765833-A2 | NEWS SALTS IN THE PREPARATION OF CEPHALOSPORIN ANTIBIOTICS | Orchid Chemicals and Pharmaceuticals Limited (IN) | 2007-03-28 | — | — | EP | claimed |
| WO-2006006040-A2 | NEWS DIAMINE SALTS OF CEPHALOSPORIN ANTIBIOTICS AND THEIR PREPARATION | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2006-01-19 | — | — | WO | claimed |
| CN-116917269-B | Process for producing isocyanate compound | Hanwha Solutions Co.,Ltd. (KR) | 2026-05-26 | — | — | CN | disclosed |
| EP-4306566-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE | ADEKA CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | ADEKA CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| US-20250273719-A1 | ION-EXCHANGE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, CELL FOR REDOX FLOW BATTERY, AND REDOX FLOW BATTERY | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4306567-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORP (JP) | 2025-06-04 | — | — | EP | disclosed |
| CN-120004763-A | Process for the preparation of isocyanate compounds comprising non-chlorinated derivatives and compositions thereof | KS试验研究株式会社 | 2025-05-16 | — | — | CN | disclosed |
| EP-1661903-A1 | NOVEL TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL WITH THE COMPLEX | Takasago International Corporation (JP) | 2006-05-31 | — | — | EP | disclosed |
| US-5312556-A | Multifunctional viscosity index improver derived from polyamine containing one primary amine group and at least one tertiary amine group and degraded ethylene copolymer | EXXON CHEMICAL PATENTS INC. (US) | 1994-05-17 | — | — | US | disclosed |
| US-5167848-A | Low temperature lubricants, dispersants | EXXON CHEMICAL PATENTS INC. (US) | 1992-12-01 | — | — | US | disclosed |
| EP-0422858-A2 | Multifunctional viscosity index improver | EXXON CHEMICAL PATENTS INC. (US) | 1991-04-17 | — | — | EP | disclosed |
| EP-0400867-A1 | Grafted viscosity index improver | EXXON CHEMICAL PATENTS INC. (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4016267-A | BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | SEM1, RER1, JMJD6 | SLC6A2 4353/4885SLC6A4 3721/4885SLC6A3 4461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.